Tommy Andersson
Affiliations: | Translational Medicine | University of Lund, Lund, Skåne län, Sweden |
Google:
"Tommy Andersson"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mehdawi LM, Ghatak S, Chakraborty P, et al. (2023) LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer. Cells. 12 |
Yadav V, Jobe N, Satapathy SR, et al. (2022) Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers. 14 |
Jobe NP, Åsberg L, Andersson T. (2021) Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion. Molecular Oncology |
Mohapatra P, Yadav V, Toftdahl M, et al. (2020) WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. Cancers. 12 |
Osman J, Bellamkonda K, Liu Q, et al. (2019) The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. Anticancer Research. 39: 1719-1728 |
Mohapatra P, Prasad CP, Andersson T. (2018) Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells. Molecular Oncology |
Prasad CP, Manchanda M, Mohapatra P, et al. (2018) WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Reviews |
Prasad CP, Andersson T. (2018) Abstract B021: Inhibition of β-catenin impairs triple-negative breast cancer (TNBC) cell migration and invasion by modulating aerobic glycolysis components Molecular Cancer Therapeutics. 17 |
Prasad CP, Södergren K, Andersson T. (2017) Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion. Oncotarget. 8: 71471-71488 |
Canesin G, Evans-Axelsson S, Hellsten R, et al. (2017) Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. Plos One. 12: e0184418 |